Presentation is loading. Please wait.

Presentation is loading. Please wait.

Solitary Papillomas of the Lower Airways: Epidemiological, Clinical, and Therapeutic Data during a 22-Year Period and Review of the Literature  Stavros.

Similar presentations


Presentation on theme: "Solitary Papillomas of the Lower Airways: Epidemiological, Clinical, and Therapeutic Data during a 22-Year Period and Review of the Literature  Stavros."— Presentation transcript:

1 Solitary Papillomas of the Lower Airways: Epidemiological, Clinical, and Therapeutic Data during a 22-Year Period and Review of the Literature  Stavros Tryfon, PhD, MD, Vasiliki Dramba, Fotis Zoglopitis, Dimitris Iakovidis, Leonidas Sakkas, Theodoros Kontakiotis, Nikolaos Galanis  Journal of Thoracic Oncology  Volume 7, Issue 4, Pages (April 2012) DOI: /JTO.0b013e d06 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 Schematic demonstration of the commonest endobronchial sites of origin for the solitary pulmonary papillomas—sum of results from our data with the literature data (% numbers mean the distribution percentage of all studied papillomas and lobes with color means most common peripheral sites of papillomas; R, right; L, left; LL, lower lobe; ML, middle lobe; UL, upper lobe). Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d06) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Schematic demonstration to the commonest symptoms and signs of the different types of solitary papillomas. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d06) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

4 Figure 3 Age distribution of the different types of solitary papillomas. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d06) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "Solitary Papillomas of the Lower Airways: Epidemiological, Clinical, and Therapeutic Data during a 22-Year Period and Review of the Literature  Stavros."

Similar presentations


Ads by Google